Target intelligence / Profile preview

Pain-conducting peripheral nerve fiber

Molecular classification
Other (peripheral nerve fibers); not a receptor, enzyme, transporter, etc.
01

Overview

Pain-conducting peripheral nerve fibers refer to the sensory nerve fibers in the peripheral nervous system responsible for transmitting noxious (painful) stimuli from the body to the central nervous system[1][2][3][4]. The two main types are **Aδ fibers** (thin, myelinated, fast-conducting, responsible for sharp, well-localized "first pain") and **C fibers** (thin, unmyelinated, slow-conducting, responsible for dull, burning, poorly localized "second pain")[1][2][3][4]. These fibers have free nerve endings in peripheral tissues and their cell bodies are located in the dorsal root ganglia. They use neuropeptides such as substance P and CGRP to signal in the spinal cord dorsal horn, and play a central role in acute and chronic pain conditions. Clarification: - This name refers to a **class of fibers, not a molecular/pharmacological target**, and does not fulfill the criteria for a canonical molecular target such as a receptor, ion channel, transporter, or enzyme. For drug development or mechanistic study, one would typically refer to specific molecular targets *expressed by* these fibers (such as voltage-gated sodium channels, TRPV1 receptors, or opioid receptors) rather than the fibers as an undifferentiated group[1][2][4].

Other names
Aδ fiberC fibernociceptive fiberperipheral pain fiber
02

Mechanism of action

Sodium channel blockade (local anesthetics) Sensory neuron desensitization (capsaicin) Neurotransmitter release modulation (opioids, gabapentinoids)

03

Biological functions

Pain transmission (nociception)Signal conduction (afferent sensory signaling)Thermal sensationItch (in some C fibers)
04

Disease associations

Chronic painNeuropathic painInflammation (as mediator of inflammatory pain)Neurodegenerative disease (as secondary effect of nerve degeneration)
05

Safety considerations

Nerve fiber damage may lead to loss of sensation, neuropathic pain, or altered sensationNon-specific targeting can cause anesthesia or loss of other sensory modalities, risk of motor impairment
06

Interacting drugs

Local anesthetics (e.g., lidocaine) block action potential conduction via sodium channel inhibition

3 more in the full profile.

07

Biomarkers

Expression levels of neuropeptides (e.g., substance P, CGRP in C fibers)Peripheral nerve conduction studies

Beyond the preview

Go deeper on Pain-conducting peripheral nerve fiber.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pain-conducting peripheral nerve fiber.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call